Psychological implications of testing positive for the BRCA gene

Timothy Pearman

doi:10.1007/978-1-4614-5891-3_11

Psychological implications of testing positive for the BRCA gene

Timothy Pearman^*

^*Corresponding author for this work

Medical Social Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Breast cancer is the most common cancer in American women with approximately 230,000 cases diagnosed annually [1]. Women in the United States have a 1 in 8 chance of developing the disease. While most cases of breast cancer do not have a strong familial component, it is estimated that approximately 5-10 % of cases of breast cancer are due to a known genetic factor [2]. In women with a known BRCA 1 or 2 mutation, 40-66 % will eventually develop breast cancer (compared to 10-12 % in the general population) [3]. In response, The American College of Medical Genetics published guidelines for genetic testing for breast and ovarian cancer in 1999.

Original language	English (US)
Title of host publication	Management of the Patient at High Risk for Breast Cancer
Publisher	Springer New York
Pages	155-160
Number of pages	6
ISBN (Electronic)	9781461458913
ISBN (Print)	1461458900, 9781461458906
DOIs	https://doi.org/10.1007/978-1-4614-5891-3_11
State	Published - Nov 1 2013

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-4614-5891-3_11

Cite this

@inbook{9960d5ba49cc4db2b8a2165aafdee826,

title = "Psychological implications of testing positive for the BRCA gene",

abstract = "Breast cancer is the most common cancer in American women with approximately 230,000 cases diagnosed annually [1]. Women in the United States have a 1 in 8 chance of developing the disease. While most cases of breast cancer do not have a strong familial component, it is estimated that approximately 5-10 % of cases of breast cancer are due to a known genetic factor [2]. In women with a known BRCA 1 or 2 mutation, 40-66 % will eventually develop breast cancer (compared to 10-12 % in the general population) [3]. In response, The American College of Medical Genetics published guidelines for genetic testing for breast and ovarian cancer in 1999.",

author = "Timothy Pearman",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2013. All rights are reserved.",

year = "2013",

month = nov,

day = "1",

doi = "10.1007/978-1-4614-5891-3_11",

language = "English (US)",

isbn = "1461458900",

pages = "155--160",

booktitle = "Management of the Patient at High Risk for Breast Cancer",

publisher = "Springer New York",

}

TY - CHAP

T1 - Psychological implications of testing positive for the BRCA gene

AU - Pearman, Timothy

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Breast cancer is the most common cancer in American women with approximately 230,000 cases diagnosed annually [1]. Women in the United States have a 1 in 8 chance of developing the disease. While most cases of breast cancer do not have a strong familial component, it is estimated that approximately 5-10 % of cases of breast cancer are due to a known genetic factor [2]. In women with a known BRCA 1 or 2 mutation, 40-66 % will eventually develop breast cancer (compared to 10-12 % in the general population) [3]. In response, The American College of Medical Genetics published guidelines for genetic testing for breast and ovarian cancer in 1999.

AB - Breast cancer is the most common cancer in American women with approximately 230,000 cases diagnosed annually [1]. Women in the United States have a 1 in 8 chance of developing the disease. While most cases of breast cancer do not have a strong familial component, it is estimated that approximately 5-10 % of cases of breast cancer are due to a known genetic factor [2]. In women with a known BRCA 1 or 2 mutation, 40-66 % will eventually develop breast cancer (compared to 10-12 % in the general population) [3]. In response, The American College of Medical Genetics published guidelines for genetic testing for breast and ovarian cancer in 1999.

UR - http://www.scopus.com/inward/record.url?scp=84929577446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929577446&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5891-3_11

DO - 10.1007/978-1-4614-5891-3_11

M3 - Chapter

AN - SCOPUS:84929577446

SN - 1461458900

SN - 9781461458906

SP - 155

EP - 160

BT - Management of the Patient at High Risk for Breast Cancer

PB - Springer New York

ER -

Psychological implications of testing positive for the BRCA gene

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this